DVA

NYSE DaVita Inc.
Oct 21, 2026 · 7:27 PM ET LAST TRADE Market Closed

$176.81 ↑ +0.00 (+0.00%) Trading Up from the previous close of $176.81, $0.67 below the day’s high of $177.48

YTD change
+55.63%
vs 20-day SMA
-1.64%
vs 200-day SMA
+1.59%

Price ranges

Previous day
$171.09 $191.20
open $189.31 close $175.35
-$13.96 (-7.37%)
Today
$171.78 $177.48
open $171.78 now $176.81
+$5.03 (+2.93%)
Past week
$171.09 $191.20
from $182.08 now $176.81
-$5.27 (-2.89%)
Past month
$171.09 $191.20
from $183.72 now $176.81
-$6.91 (-3.76%)
This year
$101.00 $247.49
from $113.61 now $176.81
+$63.20 (+55.63%)

Price & Performance

+25.45 (+16.98%) / 6M

$142.62$177.83$213.03$248.24Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 28.6% away from all-time highs of $247.49
  • DVA is up 56% since the beginning of the year
  • DVA is up 38% over the past 12 months
  • DVA is down 4% over the past 1 month
  • 8% of all DVA investors are betting against DVA
  • Number of investors short DVA has gone up 10% versus last month

DVA reads not so good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is +36.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $4.02
Earnings momentum -12.5% Quarterly EPS growth
Quarterly change -12.5%

Valuation

P/E ratio 15.39
Enterprise value $26.1B
Beta 1.17

Balance sheet & scale

Income$822.5K
Revenue$14.0B
Cash$771.8M
Debt$13.4M
Income / Debt 0.06×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Health Care and Social Assistance
Sub Sector Ambulatory Health Care Services
Market cap $11.3B

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Competitor comparison

TickerCompany PriceChange
CI Cigna Group $306.60 +2.71%
CNC Centene Corporation $70.81 +3.18%
FMCQF Fresenius Medical Care AG $43.82 +7.38%
MOH Molina Healthcare, Inc. $219.72 +4.53%
USPH U.S. Physical Therapy, Inc. $87.02 +3.71%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.